Crescent Capital BDC, Inc. Reports Third Quarter 2022 Financial Results; Declares a Fourth Quarter 2022 Regular Dividend of $0.41 per Share

Rhea-AI Summary

Crescent Capital BDC (CCAP) reported a net investment income of $16.0 million ($0.52/share) for Q3 2022, reflecting an increase from $15.5 million in Q2 2022. Adjusted net investment income stood at $13.0 million ($0.42/share). The net asset value per share decreased to $20.16 from $20.69 in Q2. The company declared a cash dividend of $0.41 per share for Q4 2022, payable January 17, 2023. Total investments rose to $1.292 billion, with a portfolio yield of 9.5%. However, net realized losses were $2.5 million, and unrealized losses totaled $15.8 million.

Positive

• Net investment income increased to $16.0 million ($0.52/share) compared to $15.5 million in Q2 2022.
• Adjusted net investment income was $13.0 million ($0.42/share).
• Total investments at fair value grew to $1,292.9 million.
• Declared a regular quarterly cash dividend of $0.41 per share.

Negative

• Net assets decreased from $639.2 million in Q2 to $622.6 million.
• Net realized losses of $2.5 million, compared to gains of $27.9 million in Q3 2021.
• Significant unrealized losses of $15.8 million.

LOS ANGELES, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $16.0 million, or $0.52 per share, and adjusted net investment income of $13.0 million, or $0.42 per share,¹ for the quarter ended September 30, 2022. Reported net asset value per share was $20.16 at September 30, 2022.

The Company announced that its Board of Directors declared a regular cash dividend for the fourth quarter 2022 of $0.41 per share, which will be paid on January 17, 2023 to stockholders of record as of the close of business on December 30, 2022.

Selected Financial Highlights
($ in millions, except per share amounts)

	As of and for the three months ended
	September 30, 2022				June 30, 2022				September 30, 2021
Investments, at fair value	$	1,292.9			$	1,285.3			$	1,138.6
Total assets	$	1,339.3			$	1,323.0			$	1,183.2
Total net assets	$	622.6			$	639.2			$	596.2
Net asset value per share	$	20.16			$	20.69			$	21.16
Investment income	$	29.0			$	26.7			$	25.5
Net investment income	$	16.0			$	15.5			$	12.7
Net realized gains (losses), net of taxes	$	(2.5	)		$	(1.8	)		$	27.9
Net change in unrealized gains (losses), net of taxes	$	(15.8	)		$	(14.6	)		$	(23.9	)
Net increase (decrease) in net assets resulting from operations	$	(2.4	)		$	(0.9	)		$	16.7
Net investment income per share	$	0.52			$	0.50			$	0.45
Net realized gains (losses) per share, net of taxes	$	(0.08	)		$	(0.06	)		$	0.99
Net change in unrealized gains (losses) per share, net of taxes	$	(0.51	)		$	(0.47	)		$	(0.85	)
Net increase (decrease) in net assets resulting from operations per share	$	(0.08	)		$	(0.03	)		$	0.59
Regular distributions paid per share	$	0.41			$	0.41			$	0.41
Special distributions paid per share	$	0.05			$	0.05				—
Non-GAAP Financial Measures1:
Adjusted net investment income	$	13.0			$	12.7			$	13.5
Adjusted net investment income per share	$	0.42			$	0.41			$	0.48
Weighted average yield on income producing securities (at cost)2		9.5	%			8.3	%			7.6	%
Percentage of debt investments at floating rates		98.7	%			98.7	%			99.7	%

Portfolio & Investment Activity

As of September 30, 2022 and December 31, 2021, the Company had investments in 136 and 134 portfolio companies with an aggregate fair value of $1,292.9 and $1,270.4 million, respectively. The portfolio at fair value was comprised of the following asset types:

Portfolio Asset Types:
		As of
$ in millions		September 30, 2022								December 31, 2021
Investment Type		Fair Value				Percentage				Fair Value				Percentage
Senior secured first lien		$	328.0				25.4	%		$	329.9				26.0	%
Unitranche first lien3			811.1				62.7				731.0				57.5
Unitranche first lien - last out3			13.1				1.0				13.7				1.1
Senior secured second lien			61.9				4.8				72.7				5.7
Unsecured debt			4.5				0.3				5.6				0.4
Equity & other			46.1				3.6				59.5				4.7
LLC/LP equity interests			28.2				2.2				58.0				4.6
Total investments		$	1,292.9				100.0	%		$	1,270.4				100.0	%

For the quarter ended September 30, 2022, the Company invested $89.8 million across 7 new portfolio companies, 9 existing portfolio companies and several follow-on revolver and delayed draw fundings. For this period, the Company had $59.7 million in aggregate exits, sales and repayments.

For the quarter ended June 30, 2022, the Company invested $112.4 million across 11 new portfolio companies, 12 existing portfolio companies and several follow-on revolver and delayed draw fundings. For this period, the Company had $97.1 million in aggregate exits, sales and repayments.

Results of Operations

For the three months ended September 30, 2022 and 2021, investment income totaled $29.0 million and $25.5 million, respectively. Interest income, which includes amortization of upfront fees, increased from $22.8 million for the three months ended September 30, 2021 to $27.2 million for the three months ended September 30, 2022, due to an expansion of the income-producing investment portfolio and a rise in benchmark rates. Included in interest from investments for the three months ended September 30, 2022 and 2021 are $0.3 million and $3.9 million of accelerated accretion of OID related to paydown activity, respectively. Dividend income decreased from $2.4 million for the three months ended September 30, 2021 to $1.6 million for the three months ended September 30, 2022, due to lower one-time dividend distributions from portfolio companies. Other income, which includes consent, waiver, amendment, agency, underwriting and arranger fees associated with our investment activities, was $0.2 million and $0.3 million for the three months ended September 30, 2022 and 2021, respectively.

For the three months ended September 30, 2022 and 2021, total net expenses, including income and excise taxes, totaled $13.0 million and $12.8 million, respectively. Interest and other debt financing costs increased from $5.7 million for the three months ended September 30, 2021 to $8.7 million for the three months ended September 30, 2022, due to higher weighted average debt outstanding and higher weighted average cost of debt related to a rise in benchmark rates. The increase in total net expenses was partially offset by a $(3.1) million reversal of capital gains based incentive fees for the three months ended September 30, 2022.

Liquidity and Capital Resources

As of September 30, 2022, the Company had $22.2 million in cash and cash equivalents and restricted cash and $193.0 million of undrawn capacity on its credit facilities, subject to borrowing base and other limitations. The weighted average interest rate on the Company’s debt outstanding as of September 30, 2022 was 5.31%.

The Company’s debt to equity ratio was 1.11x as of September 30, 2022.

Non-GAAP Financial Measures

On a supplemental basis, the Company is disclosing adjusted net investment income and adjusted net investment income per share, each of which is a financial measure that is calculated and presented on a basis of methodology other than in accordance with U.S. GAAP (“non-GAAP”). Adjusted net investment income represents net investment income, excluding capital gains incentive fees. We use this non-GAAP financial measure internally to analyze and evaluate financial results and performance and believe that this non-GAAP financial measure is useful to investors as an additional tool to evaluate ongoing results and trends without giving effect to capital gains incentive fees. The Company’s investment advisory agreement provides that a capital gains-based incentive fee is determined and paid annually with respect to realized capital gains (but not unrealized capital appreciation) to the extent such realized capital gains exceed realized capital losses and unrealized capital depreciation on a cumulative basis. We believe that adjusted net investment income is a useful performance measure because it reflects the net investment income produced on the Company’s investments during a period without giving effect to any changes in the value of such investments and any related capital gains incentive fees between periods. The presentation of adjusted net investment income is not intended to be a substitute for financial results prepared in accordance with GAAP and should not be considered in isolation.
The following table provides an unaudited reconciliation of net investment income (the most comparable U.S. GAAP measure) to adjusted net investment income for the periods presented:

		For the three months ended																								For the nine months ended September 30,
		September 30, 2022 (unaudited)								June 30, 2022 (unaudited)								September 30, 2021 (unaudited)								2022								2021
$ in millions, except per share data		Amount				Per Share				Amount				Per Share				Amount				Per Share				Amount				Per Share				Amount				Per Share
GAAP net investment income		$	16.0			$	0.52			$	15.5			$	0.50			$	12.7			$	0.45			$	43.6			$	1.41			$	35.1			$	1.25
Capital gains based incentive fee			(3.0	)			(0.10	)			(2.8	)			(0.09	)			0.8				0.03				(5.3	)			(0.17	)			6.2				0.22
Adjusted net investment income		$	13.0			$	0.42			$	12.7			$	0.41			$	13.5			$	0.48			$	38.3			$	1.24			$	41.3			$	1.47

Conference Call

The Company will host a webcast/conference call on Thursday, November 10, 2022 at 12:00 p.m. (Eastern Time) to discuss its financial results for the quarter ended September 30, 2022. Please visit Crescent BDC’s webcast link located on the Events & Presentations page of the Investor Relations section of Crescent BDC’s website for a slide presentation that complements the earnings conference call.

Those interested in participating via webcast in listen-only mode can access the event on the Investor Relations section of Crescent BDC’s website at www.crescentbdc.com. Please visit the website to test your connection before the webcast. For participants who would like to participate via telephone, please register here to receive the dial-in number along with a unique PIN number that is required to access the call.

An archived replay will be available via a webcast link located on the Investor Relations section of Crescent BDC's website.

Endnotes

Note: Numbers may not sum due to rounding.

1)	See “Non-GAAP Financial Measures” above for a description of this non-GAAP measure and a reconciliation from net investment income to adjusted net investment income. The Company's management uses this non-GAAP financial measure internally to analyze and evaluate financial results and performance and believes that this non-GAAP financial measure is useful to investors as an additional tool to evaluate ongoing results and trends for the Company without giving effect to capital gains incentive fees. The presentation of adjusted net investment income is not intended to be a substitute for financial results prepared in accordance with GAAP and should not be considered in isolation.
2)	Yield excludes investments on non-accrual status.
3)	Unitranche loans are first lien loans that may extend deeper in a company’s capital structure than traditional first lien debt and may provide for a waterfall of cash flow priority among different lenders in the unitranche loan. In certain instances, the Company may find another lender to provide the “first out” portion of such loan and retain the “last out” portion of such loan, in which case, the “first out” portion of the loan would generally receive priority with respect to payment of principal, interest and any other amounts due thereunder over the “last out” portion that the Company would continue to hold. In exchange for the greater risk of loss, the “last out” portion earns a higher interest rate.

Crescent Capital BDC, Inc.
Consolidated Statements of Assets and Liabilities
(in thousands except share and per share data)

	As of September 30, 2022 (Unaudited)				As of December 31, 2021
Assets
Investments, at fair value
Non-controlled non-affiliated (cost of $1,242,938 and $1,150,173, respectively)	$	1,224,191			$	1,165,897
Non-controlled affiliated (cost of $48,920 and $41,242, respectively)		48,923				51,701
Controlled (cost of $22,837 and $53,431, respectively)		19,759				52,768
Cash and cash equivalents		12,742				10,069
Restricted cash and cash equivalents		9,411				13,457
Unrealized appreciation on foreign currency forward contracts		12,796				2,115
Interest and dividend receivable		8,340				6,763
Deferred tax assets		99				42
Receivable for investments sold		43				14,871
Other assets		2,954				126
Total assets	$	1,339,258			$	1,317,809
Liabilities
Debt (net of deferred financing costs of $5,818 and $6,897)	$	686,145			$	631,040
Distributions payable		12,664				12,664
Interest and other debt financing costs payable		5,139				5,513
Management fees payable		4,082				3,830
Incentive fees payable		3,744				6,924
Deferred tax liabilities		1,033				956
Directors’ fees payable		148				114
Unrealized depreciation on foreign currency forward contracts		25				631
Accrued expenses and other liabilities		3,676				3,852
Total liabilities	$	716,656			$	665,524
Net assets
Preferred stock, par value $0.001 per share (10,000 shares authorized, zero outstanding, respectively)	$	-			$	-
Common stock, par value $0.001 per share (200,000,000 shares authorized, 30,887,360 shares issued and outstanding, respectively)		31				31
Paid-in capital in excess of par value		666,162				666,162
Accumulated earnings (loss)		(43,591	)			(13,908	)
Total net assets	$	622,602			$	652,285
Total liabilities and net assets	$	1,339,258			$	1,317,809
Net asset value per share	$	20.16			$	21.12

Crescent Capital BDC, Inc.
Consolidated Statements of Operations
(in thousands except share and per share data)
(Unaudited)

	For the three months ended September 30,								For the nine months ended September 30,
	2022				2021				2022				2021
Investment Income:
From non-controlled non-affiliated investments:
Interest income	$	26,047			$	22,232			$	70,490			$	60,570
Paid-in-kind interest		401				184				1,091				966
Dividend income		18				1,373				33				1,427
Other income		174				254				434				577
From non-controlled affiliated investments:
Interest income		374				305				993				904
Paid-in-kind interest		15				139				2,054				1,168
Dividend income		400				291				3,671				2,134
From controlled investments:
Interest income		192				-				558				-
Paid-in-kind interest		187				-				538				-
Dividend income		1,180				700				2,280				2,100
Total investment income		28,988				25,478				82,142				69,846
Expenses:
Interest and other debt financing costs		8,651				5,695				20,693				14,482
Management fees		4,144				3,531				12,235				10,082
Income based incentive fees		2,717				2,663				8,039				7,528
Capital gains based incentive fees		(3,103	)			757				(5,252	)			6,150
Professional fees		306				522				1,014				1,516
Directors’ fees		142				127				373				361
Other general and administrative expenses		635				692				2,001				2,076
Total expenses		13,492				13,987				39,103				42,195
Management fees waiver		(62	)			(476	)			(175	)			(3,096	)
Income based incentive fees waiver		(45	)			(931	)			(474	)			(5,796	)
Net expenses		13,385				12,580				38,454				33,303
Net investment income before taxes		15,603				12,898				43,688				36,543
(Benefit) provision for income and excise taxes		(350	)			170				64				1,403
Net investment income		15,953				12,728				43,624				35,140
Net realized and unrealized gains (losses) on investments:
Net realized gain (loss) on:
Non-controlled non-affiliated investments		(1,285	)			280				21				4,497
Non-controlled affiliated investments		-				27,513				7,113				27,513
Controlled investments		(770	)			-				(2,451	)			-
Foreign currency transactions		(73	)			80				(6	)			359
Foreign currency forward contracts		-				(56	)			24				(193	)
Net change in unrealized appreciation (depreciation) on:
Non-controlled non-affiliated investments and foreign currency translation		(14,413	)			2,897				(33,152	)			13,336
Non-controlled affiliated investments		(5,916	)			(28,198	)			(10,456	)			(12,583	)
Controlled investments		(972	)			302				(2,415	)			1,472
Foreign currency forward contracts		5,699				1,523				11,286				1,959
Net realized and unrealized gains (losses) on investments		(17,730	)			4,341				(30,036	)			36,360
Benefit (provision) for taxes on realized gain on investments		(409	)			2				(626	)			(370	)
Benefit (provision) for taxes on unrealized appreciation (depreciation) on investments		(192	)			(392	)			(20	)			(332	)
Net increase (decrease) in net assets resulting from operations	$	(2,378	)		$	16,679			$	12,942			$	70,798
Per common share data:
Net increase (decrease) in net assets resulting from operations per share (basic and diluted):	$	(0.08	)		$	0.59			$	0.42			$	2.51
Net investment income per share (basic and diluted):	$	0.52			$	0.45			$	1.41			$	1.25
Weighted average shares outstanding (basic and diluted):		30,887,360				28,167,360				30,887,360				28,167,360

About Crescent BDC

Crescent BDC is a business development company that seeks to maximize the total return of its stockholders in the form of current income and capital appreciation by providing capital solutions to middle market companies with sound business fundamentals and strong growth prospects. Crescent BDC utilizes the extensive experience, origination capabilities and disciplined investment process of Crescent. Crescent BDC is externally managed by Crescent Cap Advisors, LLC, a subsidiary of Crescent. Crescent BDC has elected to be regulated as a business development company under the Investment Company Act of 1940. For more information about Crescent BDC, visit www.crescentbdc.com. However, the contents of such website are not and should not be deemed to be incorporated by reference herein.

About Crescent Capital Group

Crescent is a global credit investment manager with over $39 billion of assets under management. For over 30 years, the firm has focused on below investment grade credit through strategies that invest in marketable and privately originated debt securities including senior bank loans, high yield bonds, as well as private senior, unitranche and junior debt securities. Crescent is headquartered in Los Angeles with offices in New York, Boston, Chicago and London with more than 200 employees globally. Crescent is a part of SLC Management, the institutional alternatives and traditional asset management business of Sun Life. For more information about Crescent, visit www.crescentcap.com. However, the contents of such website are not and should not be deemed to be incorporated by reference herein.

Contact:

Dan McMahon
daniel.mcmahon@crescentcap.com        
212-364-0149
        
Forward-Looking Statements

This press release, and other statements that Crescent BDC may make, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to Crescent BDC’s future financial or business performance, strategies or expectations. Forward-looking statements are typically identified by words or phrases such as “trend,” “potential,” “opportunity,” “pipeline,” “believe,” “comfortable,” “expect,” “anticipate,” “current,” “intention,” “estimate,” “position,” “assume,” “outlook,” “continue,” “remain,” “maintain,” “sustain,” “seek,” “achieve,” and similar expressions, or future or conditional verbs such as “will,” “would,” “should,” “could,” “may” or similar expressions.

Crescent BDC cautions that forward-looking statements are subject to numerous assumptions, risks and uncertainties, which may change over time. Forward-looking statements speak only as of the date they are made, and Crescent BDC assumes no duty to and does not undertake to update forward-looking statements. Actual results could differ materially from those anticipated in forward-looking statements and future results could differ materially from historical performance.

In addition to factors previously disclosed in Crescent BDC’s SEC reports and those identified elsewhere in this press release, the following factors, among others, could cause actual results to differ materially from forward-looking statements or historical performance: (1) our future operating results; (2) our business prospects and the prospects of our portfolio companies; (3) the impact of investments that we expect to make; (4) our contractual arrangements and relationships with third parties; (5) the dependence of our future success on the general economy and its impact on the industries in which we invest; (6) the financial condition of and ability of our current and prospective portfolio companies to achieve their objectives; (7) our expected financings and investments; (8) the adequacy of our cash resources and working capital, including our ability to obtain continued financing on favorable terms; (9) the timing of cash flows, if any, from the operations of our portfolio companies; (10) the impact of increased competition; (11) the ability of our investment adviser to locate suitable investments for us and to monitor and administer our investments; (12) potential conflicts of interest in the allocation of opportunities between us and other investment funds managed by our investment adviser or its affiliates; (13) the ability of our investment adviser to attract and retain highly talented professionals; (14) changes in law and policy accompanying the new administration and uncertainty pending any such changes; (15) increased geopolitical unrest, terrorist attacks or acts of war, which may adversely affect the general economy, domestic and local financial and capital markets, or the specific industries of our portfolio companies; (16) changes and volatility in political, economic or industry conditions, the interest rate environment, foreign exchange rates or financial and capital markets; (17) the unfavorable resolution of legal proceedings; and (18) the impact of changes to tax legislation and, generally, our tax position.

Crescent BDC’s Annual Report on Form 10-K for the year ended December 31, 2021 and quarterly report on Form 10-Q for the quarter ended September 30, 2022, each filed with the SEC, identify additional factors that can affect forward-looking statements.

Other Information

The information in this press release is summary information only and should be read in conjunction with Crescent BDC’s annual report on Form 10-K for the year ended December 31, 2021, which Crescent BDC filed with the U.S. Securities and Exchange Commission (the SEC) on February 23, 2022, Crescent BDC’s quarterly report on Form 10-Q for the quarter ended September 30, 2022, which Crescent BDC filed with the SEC on November 9, 2022, as well as Crescent BDC’s other reports filed with the SEC. A copy of Crescent BDC’s annual report on Form 10-K for the year ended December 31, 2021, Crescent BDC’s quarterly reports on Form 10-Q and Crescent BDC’s other reports filed with the SEC can be found on Crescent BDC’s website at www.crescentbdc.com and the SEC’s website at www.sec.gov.

FAQ

What were Crescent Capital BDC's Q3 2022 earnings results?

Crescent Capital BDC reported a net investment income of $16.0 million ($0.52 per share) and adjusted net investment income of $13.0 million ($0.42 per share) for Q3 2022.

What is the cash dividend declared by CCAP for Q4 2022?

Crescent Capital BDC declared a cash dividend of $0.41 per share for the fourth quarter of 2022, payable on January 17, 2023.

What was the net asset value per share for CCAP as of September 30, 2022?

The net asset value per share for Crescent Capital BDC as of September 30, 2022, was $20.16.

How did Crescent Capital BDC's investment portfolio change in Q3 2022?

Crescent Capital BDC's total investments increased to $1.292 billion in Q3 2022, up from $1.285 billion in Q2 2022.

What are the realized and unrealized gains or losses reported by CCAP?

Crescent Capital BDC reported net realized losses of $2.5 million and net unrealized losses of $15.8 million for Q3 2022.